MetroLatinoUSA

6742 Posts

Renesas Wins 2022 “Outstanding Asia-Pacific Semiconductor Company Award” by Global Semiconductor Alliance

TOKYO--(BUSINESS WIRE)--#2022GSAawards--Renesas Electronics Corporation (TSE: 6723), a premier supplier of advanced semiconductor solutions, today announced that it has received this year’s “Outstanding Asia-Pacific Semiconductor Company Award” by the Global Semiconductor Alliance (GSA). Hidetoshi Shibata, President and CEO of Renesas, and Board Member of GSA accepted the award at the Awards…
Leer más...

Spectrum Pharmaceuticals, Inc. (SPPI) Shareholder Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Spectrum Pharmaceuticals, Inc.

SAN DIEGO--(BUSINESS WIRE)--$SPPI #FDA--The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) common stock between December 6, 2021 and September 22, 2022, for violations of the Securities Exchange Act of 1934. Spectrum purports to be…
Leer más...

Veru Inc. (VERU) Shareholder Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Veru Inc.

SAN DIEGO--(BUSINESS WIRE)--$VERU #COVID19--The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Veru Inc. (NASDAQ: VERU) common stock between May 11, 2022 and November 9, 2022, for violations of the Securities Exchange Act of 1934. Veru…
Leer más...

Generac Holdings Inc. (GNRC) Shareholder Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Generac Holdings Inc.

SAN DIEGO--(BUSINESS WIRE)--$GNRC #GNRC--The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities who purchased or otherwise acquired Generac Holdings Inc. (NYSE: GNRC) common stock between April 29, 2021 and November 1, 2022. The complaint seeks damages under the Securities…
Leer más...

Teleperformance Named to PEOPLE’s Annual List of “100 Companies that Care” for 2022

Teleperformance USA recognized for demonstrating a commitment to caring for their people and their communities PARIS--(BUSINESS WIRE)--Regulatory News: Teleperformance (Paris:TEP), the global leader in outsourced customer and citizen experience management and related digital services, was named to PEOPLE’s “100 Companies that Care” for 2022. This is the sixth year that…
Leer más...

Archaea Energy Inc. (LFG) Investigation Alert: Robbins LLP is Investigating the Acquisition of Archaea Energy Inc. by BP p.l.c (BP) on Behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)--$BP #ArchaeaEnergyInc--Shareholder rights law firm Robbins LLP informs investors it is investigating the acquisition of Archaea Energy Inc. (NYSE: LFG) by BP p.l.c (NYSE: BP). Under the terms of the agreement, Archaea stockholders will receive $26.00 in cash for each share of Archaea common stock owned. If you…
Leer más...

Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286

Receives Commitment for up to $75 Million in Debtor-in-Possession Financing BOULDER, Colo.--(BUSINESS WIRE)--$CLVS--Clovis Oncology, Inc. (NASDAQ:CLVS) (“Clovis” or the Company”), a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the U.S., Europe, and additional international markets, today announced that it and certain of its subsidiaries (collectively,…
Leer más...

Ryan Specialty Signs Definitive Agreement to Acquire Griffin Underwriting Services

CHICAGO--(BUSINESS WIRE)--Ryan Specialty (NYSE: RYAN), a leading international specialty insurance firm, is pleased to announce that today it signed a definitive agreement to acquire certain assets of Griffin Underwriting Services (“Griffin”), a binding authority specialist and wholesale insurance broker headquartered in Bellevue, WA. Griffin, founded in 1928, has deep relationships…
Leer más...

Cimeio Therapeutics Presents SCIP Platform Proof-of-Concept Data at ASH

 --Preclinical data for Cimeio’s CD117- and CD123-shielded cells, and CD117 mAbs, demonstrate the potential of Cimeio’s SCIP platform to enable novel immunotherapy-based conditioning and post-transplant treatment approaches-- BASEL, Switzerland & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cimeio Therapeutics, a biotechnology company developing a novel approach to cell therapies, presented data for its CD117 and…
Leer más...